1 / 19

Modeling ‘test and treat’ for HIV in South Africa

Modeling ‘test and treat’ for HIV in South Africa. Jan AC Hontelez 1,2,3 , Mark N Lurie 4 , Till Bärnighausen 3,5 , Roel Bakker 1 Rob Baltussen 2 , Frank Tanser 3 , Timothy B Hallett 6 , Marie-Louise Newell 3 , and Sake J de Vlas 1

Download Presentation

Modeling ‘test and treat’ for HIV in South Africa

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Modeling ‘test and treat’ for HIV in South Africa Jan AC Hontelez1,2,3, Mark N Lurie4, Till Bärnighausen3,5, Roel Bakker1 Rob Baltussen2, Frank Tanser3, Timothy B Hallett6, Marie-Louise Newell3, and Sake J de Vlas1 1 Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands 2 Nijmegen International Center for Health System Analysis and Education (NICHE), Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Netherlands 3 Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa 4 Department of Epidemiology and the International Health Institute, Warren Alpert Medical School, Brown University, Providence, RI, USA 5 Department of Global Health and Population, Harvard School of Public Health, Boston, USA 6 Imperial College, London, UK Contact: j.hontelez@erasmusmc.nl

  2. Introduction Universal test and treat (UTT) suggested to drive HIV into an elimination phase (incidence < 1 / 1,000 person-years) in South Africa Many mathematical models predict impact of UTT, wide range of different results Eaton et al: Models agree on potential of ART to reduce incidence, but disagree on the amount of reduction and overall impact Objective: Examine the impact of different model structures and parameterizations on predicting the impact of UTT in South Africa using a highly controlled experiment

  3. Model A Age structured population (Model B1) Heterogeneity in transmission by HIV stage (Model B2) ModelB Heterogeneity in sexual behaviour (Model C1) HIV prevention interventions and STI co-factors (Model C2) Up-to-date ART effectiveness assumptions (Model C3) Model C Current ART scale-up in South Africa (at ≤350 cells/µL) Model D Study outline Universal HIV testing and immediate treatment for all, at 90% coverage, starting in 2012

  4. Model A Age structured population (Model B1) Heterogeneity in transmission by HIV stage (Model B2) Model B Heterogeneity in sexual behaviour (Model C1) HIV prevention interventions and STI co-factors (Model C2) Up-to-date ART effectiveness assumptions (Model C3) Model C Current ART scale-up in South Africa (at ≤350 cells/µL) Model D Model A

  5. Model A

  6. Overall effectiveness

  7. Model A Age structured population (Model B1) Heterogeneity in transmission by HIV stage (Model B2) ModelB Heterogeneity in sexual behaviour (Model C1) HIV prevention interventions and STI co-factors (Model C2) Up-to-date ART effectiveness assumptions (Model C3) Model C Current ART scale-up in South Africa (at ≤350 cells/µL) Model D

  8. Model B

  9. Overall effectiveness

  10. Model A Age structured population (Model B1) Heterogeneity in transmission by HIV stage (Model B2) ModelB Heterogeneity in sexual behaviour (Model C1) HIV prevention interventions and STI co-factors (Model C2) Up-to-date ART effectiveness assumptions (Model C3) Model C Current ART scale-up in South Africa (at ≤350 cells/µL) Model D

  11. Model C

  12. Overall effectiveness

  13. Model A Age structured population (Model B1) Heterogeneity in transmission by HIV stage (Model B2) ModelB Heterogeneity in sexual behaviour (Model C1) HIV prevention interventions and STI co-factors (Model C2) Up-to-date ART effectiveness assumptions (Model C3) Model C Current ART scale-up in South Africa (at ≤350 cells/µL) Model D

  14. Model D

  15. Overall effectiveness

  16. Conclusions and implications • We confirm results by Granich and colleagues that the HIV epidemic in South Africa can be driven into an elimination phase through expanded access to ART • Models differ substantially in predicted time till 0.1% incidence is achieved and impact of the intervention Most important components in driving differences between models: • Sexual networks • Prevalence density function versus prevention interventions • ART scale-up • Heterogeneity in HIV transmission

  17. Conclusions and implications (2) • Predicted effectiveness of UTT declines as important underlying dynamics of the epidemic are taking into account Important implications for future modeling studies on the impact of treatment as prevention • Current treatment roll-out may already have such a substantial impact that the epidemic will reach the 0.1% incidence threshold if current scale-up is maintained and universal access achieved

  18. Conclusions and implications (3) Universal test and treat intervention is still cost effective, yet assumptions on programmatic effectiveness are rather optimistic. Detailed incremental cost-effectiveness analyses with more realistic assumptions on programmatic effectiveness of treatment as prevention are needed Detailed cost-effectiveness analyses to inform policy makers and guidelines should be performed with models that allow for sufficient levels of detail in modeling the underlying epidemic

  19. Acknowledgements Co-authors Mark N Lurie Till Bärnighausen Roel Bakker Rob Baltussen Frank Tanser Timothy B Hallett Marie-Louise Newell Sake J de Vlas Funders: Bill & Melinda Gates Foundation through grants from the HIV modelling consortium NIH

More Related